Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes

Type 1 diabetes (T1D) is the third most common autoimmune disease which develops due to genetic and environmental risk factors. Often, intensive insulin therapy is insufficient, and patients require a pancreas or pancreatic islets transplant. However, both solutions are associated with many possible...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michał Wszoła, Daria Nitarska, Piotr Cywoniuk, Magdalena Gomółka, Marta Klak
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-06-01
Col·lecció:	Cells
Matèries:	stem cells pancreas 3D bioprinting diabetes CRISPR/Cas9 alpha cells
Accés en línia:	https://www.mdpi.com/2073-4409/10/6/1544
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!